Spain-based medtech company, QUIBIM, have secured €8 million in a recent round of seed funding co-led by Amadeus Capital Partners and Adara Ventures to improve its radiomics platform.
WHAT IT DOES
QUIBIM is a frontrunner in the field of radiomics, which uses artificial intelligence (AI) to read medical images for disease-specific biomarkers, enabling early detection of diseases such as COVID-19....
